QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors
Clinical trial NCT03027128 · COMPLETED
Trial details
- NCT number
- NCT03027128
- Sponsor
- ImmunityBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2019-05-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.